Insights
Breakthrough Innovation in Pediatric Cataract Treatment: Early Pilot Results Using fixOflex
Secondary opacification of the visual axis remains the most common and challenging complication after pediatric cataract surgery, occurring at significantly higher rates than in adults. Our pilot study addresses this root cause through capsule preservation.
Study Design:
In children with bilateral nuclear cataracts, we compared two approaches:
- One eye received conventional IOL implantation
- The fellow eye received fixOflex endocapsular placement before IOL implantation
Six-Month Observations:
Eyes treated with fixOflex demonstrated:
- Maintenance of clear visual axis
- Enhanced refractive stability
- Superior corrected visual acuity
- Complete absence of anterior capsule phimosis
In contrast, conventionally treated eyes showed progressive opacification and capsule phimosis requiring additional surgical interventions.
Clinical Significance:
This approach suggests potential for improved functional outcomes and reduced need for reoperation during critical developmental periods. By preserving the capsular bag's natural geometry, fixOflex addresses the root cause of complications that standard procedures allow through capsular collapse and fibrosis.
Larger cohorts and extended follow-up are essential to validate these preliminary findings.
*For professional use only. Refer to Instructions for Use (IFU) for complete indications, contraindications, and warnings.*
Insights Overview
Breakthrough Innovation in Pediatric Cataract Treatment: Early Pilot Results Using fixOflex
EYE PCR’s fixOflex Shows Promising Results in Pediatric Cataract Surgery
EYE PCR’s fixOflex Device Showcased at AAO 2024
Dr. Ioannis Pallikaris Honored at DOG 2024
EYE PCR Showcases fixOflex Endocapsular Device at ESCRS Congress in Barcelona
EYE PCR’s fixOflex Technology to be Featured in “75th IOL Anniversary Experience” at ESCRS 2024
Another Interesting case from one of our users, whereby fixOflex was used to save the day
New indications for the application of fixOflex in vitreoretinal surgery
Healio presents on Occular Surgery News video from the ESCRS 2022 in Milan
Prof. Pallikaris on Fixoflex in IOL Implantation: Insights from ESCRS 2022
EYE PCR to Present at iNovation Day During ESCRS 2022 Annual Meeting
Eye PCR to Present Poster on fixOflex at ESCRS Milan 2022 and iNovation Symposium
fixOflex Selected to Present at Cataract Extraction Session
Dr. Ahmed Elmassry Presents fixOflex Implant Study at 2022 ARVO Annual Meeting
Prof. Pallikaris along with EYE PCR team at the 36th International Congress.
Dr. Santaro Noguchi Presents fixOflex Study Results at 45th Annual Meeting of Japanese Society of Ophthalmic Surgery
Highlights from the 27th Pallas Kliniken Ophthalmological Conference: Ioannis Pallikaris Introduces fixOflex Implant
EYE PCR Presents Early Outcomes of fixOflex Clinical Trial in Alexandria
EYE PCR Expands Clinical Trials: Promising Early Results in Alexandria and Crete, 120 Cases Integrated
Promising Early Results in Alexandria and New Study Initiated in Crete
Promising Early Results from EYE PCR’s Alexandria Clinical Trial: Prof. Pallikaris Unveils fixOflex Ring
Case Report: Inhibition of Posterior Capsule Opacification with Intracapsular Ring in Phacoemulsification Cataract Surgery
EYE PCR Announces Acceptance of Poster Presentation at ESCRS 2020 and Updates on fixOflex Clinical Trials
Establishment of EYE PCR B.V.
Awards
38th HSIOIRS
Emmanouil Xilouris, Santaro Noguchi, Harilaos Ginis, Aristofanis Pallikaris
37th HSIOIRS
1st Award for the Best Free Paper Presentation: A novel Technique for a combined phacoemulsification and silicone oil procedure
Georgios Pappas, Emmanouil Xilouris, Ioannis Pallikaris
Media



